关键词: antibiotic bacterial infection nanomedicine oral drug delivery system

Mesh : Administration, Oral Anti-Bacterial Agents / administration & dosage pharmacokinetics therapeutic use Bacterial Infections / drug therapy Drug Carriers / administration & dosage chemistry Drug Delivery Systems / methods Humans Intestinal Absorption / drug effects Lipids / chemistry Nanoparticles / administration & dosage chemistry Nanotubes, Carbon / chemistry Polymers / chemistry Silicon Dioxide / chemistry Solubility

来  源:   DOI:10.2147/IJN.S279652   PDF(Sci-hub)   PDF(Pubmed)

Abstract:
Bacterial infections are the main infectious diseases and cause of death worldwide. Antibiotics are used to treat various infections ranging from minor to life-threatening ones. The dominant route to administer antibiotics is through oral delivery and subsequent gastrointestinal tract (GIT) absorption. However, the delivery efficiency is limited by many factors such as low drug solubility and/or permeability, gastrointestinal instability, and low antibacterial activity. Nanotechnology has emerged as a novel and efficient tool for targeting drug delivery, and a number of promising nanotherapeutic strategies have been widely explored to overcome these obstacles. In this review, we explore published studies to provide a comprehensive understanding of the recent progress in the area of orally deliverable nano-antibiotic formulations. The first part of this article discusses the functions and underlying mechanisms by which nanomedicines increase the oral absorption of antibiotics. The second part focuses on the classification of oral nano-antibiotics and summarizes the advantages, disadvantages and applications of nanoformulations including lipid, polymer, nanosuspension, carbon nanotubes and mesoporous silica nanoparticles in oral delivery of antibiotics. Lastly, the challenges and future perspective of oral nano-antibiotics for infection disease therapy are discussed. Overall, nanomedicines designed for oral drug delivery system have demonstrated the potential for the improvement and optimization of currently available antibiotic therapies.
摘要:
暂无翻译
公众号